Description
Nateglinide (nateglinide) is a glinide listed in our Other diabetes tablets and Type 2 diabetes medications directories and prescribed for type 2 diabetes (1.1) (2.1). Administered via the oral route, Nateglinide is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Nateglinide is a medication containing the active pharmaceutical ingredient nateglinide, classified pharmacologically as a glinide (2.1). It is clinically indicated for the management of type 2 diabetes as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Other diabetes tablets section of our catalogue, patients and prescribers frequently review Nateglinide alongside related therapies such as Glinate (Nateglinide), Starlix (Nateglinide), Prandin (Repaglinide), and Repaglinide.
Official Indications and Usage
Nateglinide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations of use: Nateglinide should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. (1.1)
Mechanism of Action and Pharmacology
Nateglinide lowers blood glucose levels by stimulating insulin secretion from the pancreas. This action is dependent upon functioning beta-cells in the pancreatic islets. Nateglinide interacts with the ATP-sensitive potassium (K + ATP ) channel on pancreatic beta-cells. The subsequent depolarization of the beta cell opens the calcium channel, producing calcium influx and insulin secretion. The extent of insulin release is glucose dependent and diminishes at low glucose levels. (1.1) (1.1)
What is Type 2 diabetes?
Type 2 diabetes involves high blood glucose because the body does not use insulin effectively and may not make enough. Treatment depends on individual glucose, heart, kidney, and other health needs. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Type 2 diabetes condition guide for appointment questions and related therapies (3.1).
Ordering Nateglinide from Canada for U.S. Delivery
U.S. patients can order Nateglinide (Nateglinide) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Nateglinide |
| Chemical / Generic Name | Nateglinide |
| Pharmacological Class | Glinide |
| Therapeutic Category | Type 2 diabetes medications · Other diabetes tablets |
| Same-Ingredient Catalogue Entries | Glinate (Nateglinide), Starlix (Nateglinide) |
| Molecular Formula | C19H27NO3 (2.1) |
| Molecular Weight | 317.4 g/mol (2.1) |
| IUPAC Chemical Name | (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid |
| Bioavailability | ~73% (1.1) |
| Elimination Half-Life | ~1.5 hours (1.1) |
| Time to Peak Plasma Level (Tmax) | 1 hour (2.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NIH PubChem, NLM MedlinePlus |
| Routes of Administration | Oral |
| Dosage Forms & Strengths | 60 mg tablets: Pink color coated, round biconvex, beveled edge tablet debossed with "P 984" on one side and plain on the other side 120 mg tablets: Orange |
| Primary Indications | Type 2 Diabetes |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| PubChem CID | 5311309 |
| FDA UNII Identifier | 41X3PWK4O2 |
| NLM RxNorm Concept ID (RxCUI) | 311919, 314142 |
| FDA Application License | ANDA077463 |
| Official DailyMed SetID | e920b343-f53e-7487-e053-2995a90a719a |
| Catalogue Index Links | Letter N Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
The recommended dose of nateglinide is 120 mg orally three times daily before meals. Instruct patients to take nateglinide 1 to 30 minutes before meals. In patients who skip meals, instruct patients to skip the scheduled dose of nateglinide to reduce the risk of hypoglycemia. Recommended dose is 120 mg three times daily In patients who are near glycemic goal when treatment is initiated, 60 mg three times daily may be administered. Administer 1 to 30 minutes before meals If a meal is skipped, skip the scheduled dose to reduce the risk of hypoglycemia. (1.1)
Presentations and Strengths
60 mg tablets: Pink color coated, round biconvex, beveled edge tablet debossed with "P 984" on one side and plain on the other side 120 mg tablets: Orange color coated, oval shaped biconvex, tablet debossed with "P 985" on one side and plain on the other side Tablets: 60 mg and 120 mg. (1.1)
Administration Guidance
Take Nateglinide orally at the same time(s) each day as directed on your prescription label (1.1). Check with your pharmacist whether your specific formulation should be taken with a meal or on an empty stomach, and swallow extended-release or film-coated tablets whole without crushing, chewing, or splitting unless the tablet is scored and your prescriber has instructed you to do so.
Missed Dose Guidance
If you miss a scheduled dose of Nateglinide, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Nateglinide is nateglinide (molecular formula C19H27NO3, molecular weight 317.4 g/mol) (2.1) (2.1). Other catalogue entries containing nateglinide include Glinate (Nateglinide) and Starlix (Nateglinide).
Inactive Ingredients (Excipients)
According to the U.S. FDA product labeling, formulation excipients include colloidal silicon dioxide, croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch (starch 1500 ® ) (1.1). Inactive ingredients can vary slightly between different manufacturers and international or generic presentations; review the dispensed carton if you have known excipient sensitivities.
Cautions and important safety information
Contraindications
Nateglinide tablets are contraindicated in patients with a history of hypersensitivity to nateglinide or its inactive ingredients. (1.1)
Key Clinical Precautions
Before starting or continuing Nateglinide, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Hypoglycemia (low blood sugar): When used alongside insulin therapies or insulin secretagogues (such as sulfonylureas), the risk of hypoglycemia increases. Patients may need a lower dose of their secretagogue or insulin and should recognize symptoms like shakiness, sweating, fast heartbeat, dizziness, and confusion.
- Seizure threshold: This medication may lower the seizure threshold or require caution in patients with a history of seizure disorders or conditions that predispose to seizures.
Pregnancy, Lactation, and Special Populations
The available data from published literature and the applicant's pharmacovigilance with use of nateglinide in pregnant women are insufficient to identify a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. There are risks to the mother and fetus associated with poorly controlled diabetes in pregnancy. Nateglinide should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. (1.1)
Interactions
Official Drug Interaction Overview
Drugs That May Increase the Blood-Glucose-Lowering Effect of Nateglinide and Susceptibility to Hypoglycemia Drugs: Nonsteroidal anti-inflammatory drugs (NSAIDs), salicylates, monoamine oxidase inhibitors, non-selective beta-adrenergic-blocking agents, anabolic hormones (e.g., methandrostenolone), guanethidine, gymnema sylvestre, glucomannan, thioctic acid, and inhibitors of CYP2C9 (e.g., amiodarone, fluconazole, voriconazole, sulfinpyrazone) or in patients known to be poor metabolizers of CYP2C9 substrates, alcohol. Intervention: Dose reductions and increased frequency of glucose monitoring may be required when nateglinide is coadministered with these drugs. (1.1)
Important Interaction Categories
Concomitant use of Nateglinide with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Nonsteroidal anti-inflammatory drugs (NSAIDs in our Pain and inflammation directory, such as Celebrex (Celecoxib) or Meloxicam): Combining NSAIDs with this medication may reduce renal perfusion, diminish antihypertensive or diuretic efficacy, or increase the risk of gastrointestinal bleeding and acute kidney injury.
- Monoamine oxidase inhibitors (MAOIs, such as phenelzine, tranylcypromine, selegiline, or linezolid): Concomitant use or use within 14 days of stopping an MAOI can cause severe drug interactions, including hypertensive crisis, serotonin syndrome, or enhanced hypoglycemic and central nervous system effects.
- Alcohol: Excessive alcohol consumption can potentiate blood-sugar fluctuations, increase the risk of lactic acidosis or ketoacidosis in metabolic therapies, heighten gastrointestinal irritation, or increase drowsiness and orthostatic dizziness.
Side effects
Like all medications, Nateglinide can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Diarrhea (loose stools): Maintain adequate fluid and electrolyte intake; contact your prescriber if diarrhea is severe or persistent.
- Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
- Skin rash: Mild skin eruptions can occur; seek immediate care if a rash blisters, peels, or is accompanied by fever.
Clinical Trial and Postmarketing Adverse Reactions
The following serious adverse reaction is also described elsewhere in the labeling: Hypoglycemia Common adverse reactions associated with nateglinide (3% or greater incidence) were upper respiratory tract infection, back pain, flu symptoms, dizziness, arthropathy, diarrhea. In clinical trials, approximately 2,600 patients with type 2 diabetes mellitus were treated with nateglinide. Of these, approximately 1,335 patients were treated for 6 months or longer and approximately 190 patients for one year or longer. (1.1)
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Nateglinide Tablets, USP are supplied in the following package and dose strength forms: 60 mg Pink color coated, round biconvex, beveled edge tablet debossed with "P 984" on one side and plain on the other side. Bottles of 100……………NDC 51407-656-01 120 mg Orange color coated, oval shaped biconvex, tablet debossed with "P 985" on one side and plain on the other side. Bottles of 100……………NDC 51407-657-01 Storage and Handling Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F). Dispense in a tight, light resistant container. (1.1)
Store Nateglinide in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).
What is a generic drug?
A generic medication contains the exact same active pharmaceutical ingredient (nateglinide) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.
While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.
Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Type 2 diabetes medications directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.
Related Medications in Our Catalogue
- Glinate (Nateglinide), listed in Type 2 diabetes medications
- Starlix (Nateglinide), listed in Type 2 diabetes medications
- Prandin (Repaglinide), listed in Type 2 diabetes medications
- Repaglinide, listed in Type 2 diabetes medications
- Amaryl (Glimepiride), listed in Type 2 diabetes medications
- Avandia (Rosiglitazone), listed in Type 2 diabetes medications
Related Categories, Directories, and Ordering Guides
- Other diabetes tablets Category Directory
- Type 2 diabetes medications Category Directory
- Medications Starting with N
- Active Ingredient Directory
- What to prepare before a prescription order
- How to compare prescription prices without mixing up the product
- How to Order Prescription Medication
- Prescription Requirements
- Ordering Medication from Canada Guide
- Caregiver Ordering Guide
- Explore Medications
- Explore Categories
- Explore Diabetes
- Explore Pain Inflammation
- Explore Celebrex Celecoxib
- Explore Meloxicam Generic
Frequently Asked Questions About Nateglinide
What is Nateglinide and what active ingredient does it contain?
Nateglinide is a glinide containing the active pharmaceutical ingredient nateglinide (chemical formula C19H27NO3). It is supplied for oral administration and requires a valid prescription where applicable.
How does Nateglinide work in the body?
Nateglinide lowers blood glucose levels by stimulating insulin secretion from the pancreas. This action is dependent upon functioning beta-cells in the pancreatic islets. Nateglinide interacts with the ATP-sensitive potassium (K + ATP ) channel on pancreatic beta-cells.
What conditions is Nateglinide prescribed to treat?
Nateglinide is primarily indicated for type 2 diabetes. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Nateglinide?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Nateglinide is administered via the oral route. Take it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Nateglinide?
Commonly reported side effects of Nateglinide include loose stools, dizziness, and rash. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Nateglinide?
Important interaction categories for Nateglinide include nonsteroidal anti-inflammatory medicines, monoamine oxidase inhibitors, and alcohol. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Nateglinide be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Nateglinide to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Nateglinide online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Nateglinide (Nateglinide) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
What is the brand-name version of Nateglinide (Nateglinide) at a Canada pharmacy?
How is Nateglinide shipped to U.S. residents, and how much does shipping cost?
Nateglinide ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Nateglinide prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Nateglinide prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Nateglinide are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Nateglinide. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) PubChem Compound Summary for cid 5311309 (Nateglinide). National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine. Official regulatory & clinical reference. (Accessed 2026-10-29).
- (3.1) MedlinePlus Medical Encyclopedia: Diabetes Type 2. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (4.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
